Literature DB >> 31713221

Hispanics/Latinos in the Bronx Have Improved Survival in Non-Small Cell Lung Cancer Compared with Non-Hispanic Whites.

Madelyn Klugman1, Xiaonan Xue2, Mindy Ginsberg2, Haiying Cheng3, Thomas Rohan2, H Dean Hosgood2.   

Abstract

BACKGROUND: Hispanics/Latinos are a growing yet understudied population in the United States (US). Despite lower socioeconomic status, Hispanics/Latinos tend to have similar or better health outcomes than Non-Hispanic Whites (NHWs). This phenomenon has not been conclusively studied for lung cancer.
METHODS: Using a cohort of patients at Montefiore Medical Center (MMC) in the Bronx, NY, we examined factors related to lung cancer survival by race/ethnicity with an emphasis on Hispanics/Latinos. Subjects were diagnosed with non-small cell lung cancer (NSCLC) between 2004 and 2017. Demographic and clinical data were obtained from MMC's clinical systems and tumor-related information from MMC/Einstein's Cancer Registry. Survival was assessed using Cox proportional hazards modeling adjusted for clinical and sociodemographic factors including smoking. Factors related to survival within each major racial/ethnic group were examined.
RESULTS: Hispanics/Latinos experienced decreased risk of death relative to NHWs [hazard ratio (HR) = 0.70, 95% confidence interval (95%CI) 0.57-0.86] overall and by sex (males: HR = 0.78, 95%CI 0.59-1.03, females: HR = 0.61, 95%CI 0.44-0.86). Decreased risk among Hispanics/Latinos relative to NHWs was evident in never-smokers (HR = 0.55, 95%CI 0.29-1.01), ever-smokers (HR = 0.72, 95%CI 0.57-0.90), younger subjects (HR = 0.73, 95%CI 0.54-0.99), and older subjects (HR = 0.72, 95%CI 0.53-0.97). Surgery was associated with improved survival in Hispanics/Latinos (HR = 0.60, 95%CI 0.43-0.85), and smoking with worse survival (HR = 1.56, 95%CI 1.02-2.39). Survival did not differ between Non-Hispanic Blacks and NHWs.
CONCLUSIONS: In a poor urban community, Hispanics/Latinos experience improved survival from NSCLC compared to NHWs, which is not entirely explained by smoking. Future research should investigate the drivers of this benefit and differences in survival by Hispanic/Latino origin.

Entities:  

Keywords:  Epidemiology; Ethnicity; Lung; Mortality; Race

Mesh:

Year:  2019        PMID: 31713221      PMCID: PMC7067621          DOI: 10.1007/s40615-019-00660-2

Source DB:  PubMed          Journal:  J Racial Ethn Health Disparities        ISSN: 2196-8837


  41 in total

1.  Genotyping non-small cell lung cancer (NSCLC) in Latin America.

Authors:  Oscar Arrieta; Andrés Felipe Cardona; Guillermo Federico Bramuglia; Aly Gallo; Alma D Campos-Parra; Silvia Serrano; Marcelo Castro; Alejandro Avilés; Edgar Amorin; Ricardo Kirchuk; Mauricio Cuello; José Borbolla; Omar Riemersma; Henry Becerra; Rafael Rosell
Journal:  J Thorac Oncol       Date:  2011-11       Impact factor: 15.609

2.  The Impact of Salmon Bias on the Hispanic Mortality Advantage: New Evidence from Social Security Data.

Authors:  Cassio M Turra; Irma T Elo
Journal:  Popul Res Policy Rev       Date:  2008

3.  Smoking cessation among U.S. Hispanic/Latino adults: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Authors:  Cheryl R Merzel; Carmen R Isasi; Garrett Strizich; Sheila F Castañeda; Marc Gellman; Aida L Maisonet Giachello; David J Lee; Frank J Penedo; Krista M Perreira; Robert C Kaplan
Journal:  Prev Med       Date:  2015-10-26       Impact factor: 4.018

4.  Association of Early Palliative Care Use With Survival and Place of Death Among Patients With Advanced Lung Cancer Receiving Care in the Veterans Health Administration.

Authors:  Donald R Sullivan; Benjamin Chan; Jodi A Lapidus; Linda Ganzini; Lissi Hansen; Patricia A Carney; Erik K Fromme; Miguel Marino; Sara E Golden; Kelly C Vranas; Christopher G Slatore
Journal:  JAMA Oncol       Date:  2019-12-01       Impact factor: 31.777

5.  The Hispanic Paradox: Race/Ethnicity and Nativity, Immigrant Enclave Residence and Cognitive Impairment Among Older US Adults.

Authors:  Margaret M Weden; Jeremy N V Miles; Esther Friedman; José J Escarce; Christine Peterson; Kenneth M Langa; Regina A Shih
Journal:  J Am Geriatr Soc       Date:  2017-03-28       Impact factor: 5.562

6.  Explaining low mortality among US immigrants relative to native-born Americans: the role of smoking.

Authors:  Laura Blue; Andrew Fenelon
Journal:  Int J Epidemiol       Date:  2011-02-15       Impact factor: 7.196

7.  Parsing the Paradox: Hispanic Mortality in the US by Detailed Cause of Death.

Authors:  Jill Anne McDonald; Leonard Joseph Paulozzi
Journal:  J Immigr Minor Health       Date:  2019-04

8.  EGFR mutations in US Hispanic versus non-Hispanic white patients with lung adenocarcinoma.

Authors:  Wei Zhang; Elizabeth B McQuitty; Randall Olsen; Hongxin Fan; Heather Hendrickson; Fermin O Tio; Keith Newton; Philip T Cagle; Jaishree Jagirdar
Journal:  Arch Pathol Lab Med       Date:  2013-08-12       Impact factor: 5.534

9.  Impact of neighborhood and individual socioeconomic status on survival after breast cancer varies by race/ethnicity: the Neighborhood and Breast Cancer Study.

Authors:  Salma Shariff-Marco; Juan Yang; Esther M John; Meera Sangaramoorthy; Andrew Hertz; Jocelyn Koo; David O Nelson; Clayton W Schupp; Sarah J Shema; Myles Cockburn; William A Satariano; Irene H Yen; Ninez A Ponce; Marilyn Winkleby; Theresa H M Keegan; Scarlett L Gomez
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-03-11       Impact factor: 4.090

10.  How do social factors explain outcomes in non-small-cell lung cancer among Hispanics in California? Explaining the Hispanic paradox.

Authors:  Manali I Patel; Clayton W Schupp; Scarlett L Gomez; Ellen T Chang; Heather A Wakelee
Journal:  J Clin Oncol       Date:  2013-08-19       Impact factor: 50.717

View more
  1 in total

1.  Prognosis and Survival Analysis of 922,317 Lung Cancer Patients from the US Based on the Most Recent Data from the SEER Database (April 15, 2021).

Authors:  Sheng Hu; Wenxiong Zhang; Qiang Guo; Jiayue Ye; Deyuan Zhang; Yang Zhang; Weibiao Zeng; Dongliang Yu; Jinhua Peng; Yiping Wei; Jianjun Xu
Journal:  Int J Gen Med       Date:  2021-12-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.